MetLife Investment Management, LLC
Position in TBPH — Theravance Biopharma, Inc.
CIK 1529735
Whippany, NJ
Position in TBPH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$346,883
-$60,022 QoQ
Shares Held
21,373
-1.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $359,688,098 across 207 Biotechnology names. TBPH ranks #115 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in TBPH
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $346,883 | 21,373 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $406,905 | 21,748 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $359,641 | 24,633 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $294,148 | 26,668 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $238,145 | 26,668 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $250,945 | 26,668 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $214,944 | 26,668 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $233,751 | 27,565 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $197,483 | 22,016 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $332,456 | 29,578 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $292,919 | 33,942 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $351,299 | 33,942 | Shares | Defined | 2023-08-10 | |
| 2022-12-31 | $380,829 | 33,942 | Shares | Defined | 2023-06-14 | |
| 2022-09-30 | $344,171 | 33,942 | Shares | Defined | 2023-06-14 | |
| 2022-06-30 | $307,514 | 33,942 | Shares | Defined | 2023-06-20 | |
| 2022-03-31 | $324,485 | 33,942 | Shares | Defined | 2023-06-20 | |
| 2021-12-31 | $241,464 | 21,852 | Shares | Defined | 2023-06-21 | |
| 2021-09-30 | $48,499 | 6,554 | Shares | Defined | 2023-06-21 | |
| 2021-03-31 | $378,074 | 18,524 | Shares | Defined | 2023-06-26 | |
| 2020-12-31 | $377,683 | 21,254 | Shares | Defined | 2023-06-22 | |
| 2020-09-30 | $314,240 | 21,254 | Shares | Defined | 2023-06-26 | |
| 2020-06-30 | $446,121 | 21,254 | Shares | Defined | 2023-06-26 | |
| 2020-03-31 | $491,179 | 21,254 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||